Agomab Therapeutics NV（AGMB）の株価予測

$9.050

-0.205 (-2.27%)終値時点

価格予想

1-Day Price Prediction

+0.26%

1-Week Prediction

+0.13%

1-Month Prediction

—

2026 Prediction

—

2030 Prediction

—

アプリで開くと、より長期の予想を確認できます。

Loading chart…

類似チャート分析による AGMB の予測・予想

Alphio's AGMB stock price prediction model matches the current Agomab Therapeutics NV tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $9.07 (+0.26%). The 1-week path is $9.06 (+0.13%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Agomab Therapeutics NV 株は買うべき？

Agomab Therapeutics is a good buy right now due to its promising clinical developments and strong analyst support. The stock is currently priced at $9.05, with a significant upside potential indicated by analyst targets ranging from $34 to $60. Additionally, the recent Phase 2b trial initiation for its drug Ontunisertib in Crohn's disease positions the company well in a market projected to grow significantly, which is a strong positive catalyst. However, the company is currently facing a negative net income of -11.73 million EUR for Q4 2024, which represents a risk to its financial stability.